Genmab A/S (GNMSF) Net Margin (2018 - 2026)
Genmab A's (GNMSF) quarterly Net Margin came in at 634.15% in Q1 2026, down 10655.0% YoY from N/an in Q1 2025, and up 193.53% on a QoQ basis from 216.04% in Q3 2025.
Genmab A/S (GNMSF) Net Margin (2018 - 2026) Analysis & Trends
Genmab A (GNMSF) has 5 years of Net Margin data on file, last reported at 634.15% in Q1 2026.
- Quarterly Net Margin fell 10655.0% year-over-year to 634.15% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 202.33% (down 1165.0% YoY) and the FY2025 annual result came in at 25.89%, down 13871.0% from the prior year.
- Net Margin grew to 634.15% in Q1 2026, from 216.04% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 781.59% in Q1 2024 to a low of 28.58% in Q2 2024.
- A 3-year average of 378.79% and a median of 218.06% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2025 — Net Margin soared 380 bps — and 2026, when it plunged 10655 bps.
- Tracing GNMSF's Net Margin over 3 years: stood at 218.06% in 2024, then dropped by 1 bps to 216.04% in 2025, then soared by 194 bps to 634.15% in 2026.
- The last three Net Margin figures came in at 634.15% (Q1 2026), 216.04% (Q3 2025), and 32.38% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.23% |
| Mar 31, 2026 | 634.15% |
| Sep 30, 2025 | 216.04% |
| Jun 30, 2025 | 32.38% |
| Mar 31, 2025 | 740.70% |
| Sep 30, 2024 | 218.06% |
| Jun 30, 2024 | 28.58% |
| Mar 31, 2024 | 781.59% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 67,248,451,958,178.34% |
| Dec 31, 2018 | 0.00% |